A Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic HCV

NCT05904470 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

275

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C Virus
Hepatitis C, Chronic
Hepatitis C
Hepatic Cirrhosis
HCV

Interventions

DRUG: Bemnifosbuvir
DRUG: Ruzasvir

Sponsor

Atea Pharmaceuticals, Inc.